×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
Caveolin-1 Antikörper (AA 1-100)
CAV1
Reaktivität: Human
WB, IHC, IF
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN6137992
Produktdetails anti-Caveolin-1 Antikörper
(ausblenden)
Target
Alle Caveolin-1 (CAV1) Antikörper anzeigen
Caveolin-1 (CAV1)
(Caveolin 1, Caveolae Protein, 22kDa (CAV1))
Bindungsspezifität
Alle Epitope für Caveolin-1 Antikörper
AA 1-100
Reaktivität
Alle Reaktivitäten für Caveolin-1 Antikörper
Human
Wirt
Alle Wirte für Caveolin-1 Antikörper
Kaninchen
Klonalität
Alle Klonalitäten für Caveolin-1 Antikörper
Polyklonal
Konjugat
Alle Konjugate für Caveolin-1 Antikörper
Dieser Caveolin-1 Antikörper ist unkonjugiert
Applikation
Alle Applikationen für Caveolin-1 Antikörper
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
Sequenz
MSGGKYVDSE GHLYTVPIRE QGNIYKPNNK AMADELSEKQ VYDAHTKEID LVNRDPKHLN DDVVKIDFED VIAEPEGTHS FDGIWKASFT TFTVTKYWFY
Kreuzreaktivität
Human, Maus, Ratte
Produktmerkmale
Polyclonal Antibodies
Aufreinigung
Affinity purification
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 1-100 of human Caveolin-1 (NP_001744.2).
Isotyp
IgG
Top Product
Discover our top product CAV1 Primärantikörper
Alternativen
(anzeigen)
anti-Caveolin 1, Caveolae Protein, 22kDa (CAV1) (AA 2-120) antibody
CAV1
Reaktivität: Human, Ratte, Maus
WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro), FACS
Wirt: Kaninchen
Polyclonal
unconjugated
Anwendungsinformationen
(ausblenden)
Applikationshinweise
WB,1:500 - 1:2000,IHC,1:50 - 1:200,IF,1:50 - 1:200
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Format
Liquid
Buffer
PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C. Avoid freeze / thaw cycles.
Details zu Caveolin-1
(ausblenden)
Target
Caveolin-1 (CAV1)
(Caveolin 1, Caveolae Protein, 22kDa (CAV1))
Andere Bezeichnung
CAV1 (CAV1 Produkte )
Synonyme
fc07c04 antikoerper, wu:fc07c04 antikoerper, Cav-1 antikoerper, bscl3 antikoerper, cav1 antikoerper, cav1a antikoerper, cgl3 antikoerper, vip21 antikoerper, cav1b antikoerper, caveolin-1 antikoerper, cav antikoerper, mstp085 antikoerper, Caveolin-1 antikoerper, CAV1 antikoerper, cav-1 antikoerper, Cav antikoerper, caveolin 1 antikoerper, BSCL3 antikoerper, CGL3 antikoerper, MSTP085 antikoerper, PPH3 antikoerper, VIP21 antikoerper, caveolin 1 antikoerper, caveolin 1 L homeolog antikoerper, caveolin 1 S homeolog antikoerper, caveolin 1, caveolae protein antikoerper, caveolin 1, caveolae protein, 22kDa antikoerper, Caveolin antikoerper, cav1 antikoerper, cav1.L antikoerper, cav1.S antikoerper, CAV1 antikoerper, Cav1 antikoerper, cav-1 antikoerper
Hintergrund
The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.,BSCL3,CGL3,LCCNS,MSTP085,PPH3,VIP21,CAV1,Cancer,Tumor biomarkers,Signal Transduction,ErbB-HER Signaling Pathway,Cell Biology & Developmental Biology,Cell Adhesion,Endocrine & Metabolism,Lipid Metabolism,Cholesterol Metabolism,Insulin Receptor Signaling Pathway,Cardiovascular,Hypoxia,Lipids,CAV1
Molekulargewicht
17 kDa/20 kDa
Gen-ID
857
UniProt
Q03135
Pathways
Maintenance of Protein Location , Signaling Events mediated by VEGFR1 and VEGFR2 , Negative Regulation of Transporter Activity , VEGFR1 Specific Signals
Zuletzt angesehen
(ausblenden)